| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.31 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |